A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma

NCT05100628 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

Metastatic Soft-tissue Sarcoma

Interventions

DRUG: NOX66
DRUG: NOX66
DRUG: NOX66
DRUG: NOX66
DRUG: Doxorubicin

Sponsor

Noxopharm Limited